Mydecine Innovations Group: Funding, Investors & Team (Sep 2026)
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.
Mydecine Innovations Group has raised $250k across 1 funding round on record, the most recent a Post-IPO Equity of $250k announced in Aug 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mydecine Innovations Group Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Mydecine Innovations Group Funding Rounds
Mydecine Innovations Group Founders and Leadership Team
Contact details for the Mydecine Innovations Group team: 1 of 1 has an email address on file.
Start 14-day free trial →Mydecine Innovations Group Funding Compared to Other Biotechnology Startups
Mydecine Innovations Group's latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mydecine Innovations Group in Biotechnology and Vancouver
Companies Similar to Mydecine Innovations Group
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Mydecine Innovations Group Funding FAQs
What does Mydecine Innovations Group do?
Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders. They use a world-class technology and drug development infrastructure, and advances new treatment options in areas of significant unmet need. Founded in 2020, the company is based in Vancouver, British Columbia, Canada.
How much funding has Mydecine Innovations Group raised?
Mydecine Innovations Group has raised $250k across 1 round on record. The most recent is a Post-IPO Equity of $250k announced in Aug 2022.
When did Mydecine Innovations Group last raise funding?
Mydecine Innovations Group's most recent funding round on record is a Post-IPO Equity of $250k, announced in Aug 2022.
Who founded Mydecine Innovations Group?
FundedIQ lists Damon Michaels (Founder) at Mydecine Innovations Group.
Where is Mydecine Innovations Group headquartered?
Mydecine Innovations Group is based in Vancouver, British Columbia, Canada.
How many employees does Mydecine Innovations Group have?
Mydecine Innovations Group is in the 11-50 employee band.
How does Mydecine Innovations Group's funding compare to other Biotechnology startups?
Mydecine Innovations Group's latest round of $250k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Mydecine Innovations Group Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mydecine Innovations Group is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.